Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
While efficacious treatments are available for HIV, they require lifelong adherence and can have harmful effects over time. Therefore, developing novel treatments and a preventative vaccine remain critical. While most vaccine attempts to date have been largely unsuccessful, identifying new targets on the virus, may provide novel avenues for HIV vaccines and therapies. Integrin alpha 4 beta 7 (?4?7) is a cellular protein that is highly abundant within the external HIV envelope that has been shown to facilitate trafficking of virus to their target cells in an animal model. This protein is also known to play several roles in HIV infection. My projects aims to determine what mechanisms are in place that allow ?4?7 and (other cellular proteins) to partition into the HIV envelope which may in turn provide new information on how the virus is able to hijack other human proteins to increase its infectivity.
Christina Guzzo
National Institute of Allergy and Infectious Diseases
Life Sciences
Health and Related Sciences & Technology; Life Sciences (not health)
University of Toronto
Globalink Research Award
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.